Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Net Cash Flow (2019 - 2025)

Silo Pharma (SILO) has disclosed Net Cash Flow for 7 consecutive years, with $831073.0 as the latest value for Q4 2025.

  • Quarterly Net Cash Flow rose 187.02% to $831073.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.3 million through Dec 2025, down 427.94% year-over-year, with the annual reading at $842901.0 for FY2025, 120.95% up from the prior year.
  • Net Cash Flow hit $831073.0 in Q4 2025 for Silo Pharma, up from -$416045.0 in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $6.1 million in Q3 2021 to a low of -$6.7 million in Q1 2023.
  • Historically, Net Cash Flow has averaged -$164181.8 across 5 years, with a median of -$455013.0 in 2021.
  • Biggest five-year swings in Net Cash Flow: surged 3518.95% in 2021 and later crashed 1212.59% in 2023.
  • Year by year, Net Cash Flow stood at -$424415.0 in 2021, then crashed by 108.76% to -$885989.0 in 2022, then soared by 475.23% to $3.3 million in 2023, then crashed by 128.73% to -$955091.0 in 2024, then soared by 187.02% to $831073.0 in 2025.
  • Business Quant data shows Net Cash Flow for SILO at $831073.0 in Q4 2025, -$416045.0 in Q3 2025, and -$897166.0 in Q2 2025.